Brand name: Cabenuva Generic name: cabotegravir and rilpivirine Company: Janssen Pharmaceuticals, Inc. Treatment for: HIV Infection
Cabenuva (rilpivirine and cabotegravir) is available as an oral and injectable, two-drug regimen of long-acting rilpivirine and the investigational integrase inhibitor cabotegravir, for the treatment of HIV in adults.
Uses of Cabenuva
Side effects of Cabenuva
Consult your doctor immediately if any side effects occur, worsen, persist or any serious side effects occur.